Liraglutide 71288-0563
Product NDC
71288-0563- Manufacturer
- Meitheal Pharmaceuticals Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 2, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA218115
Need to source Liraglutide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Liraglutide | 6 mg/mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Packaging Options(2)
3 SYRINGE, PLASTIC in 1 CARTON (71288-563-84) / 3 mL in 1 SYRINGE, PLASTIC
2 SYRINGE, PLASTIC in 1 CARTON (71288-563-85) / 3 mL in 1 SYRINGE, PLASTIC